Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025GlobeNewsWire • 02/18/25
Meet the Growth Stock That Could Soar 280%, According to Wall Street AnalystsThe Motley Fool • 01/27/25
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the marketCNBC • 01/08/25
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?The Motley Fool • 12/17/24
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory OfficerGlobeNewsWire • 11/26/24
IOVA Posts Narrower-Than-Expected Q3 Loss, Amtagvi Sales Drive Top lineZacks Investment Research • 11/08/24
Iovance Biotherapeutics (IOVA) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/07/24
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024GlobeNewsWire • 11/07/24
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024GlobeNewsWire • 10/31/24